share_log

歌禮製藥-B:翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Feb 22 04:24
Summary by Moomoo AI
歌禮製藥有限公司於2024年2月22日向香港聯合交易所有限公司提交了翌日披露報表,披露了自2023年12月19日至2024年2月22日期間,公司未註銷的股份購回情況。根據報表,公司在此期間共購回了69,771,000股普通股,佔已發行股份的6.4179%。最後一次購回發生在2024年2月22日,當日購回480,000股,每股價格介乎HKD 1.87至HKD 1.9,總共支付了HKD 908,150。購回後,公司於2024年2月22日的結存為1,044,821,000股。公司確認,所有購回行動均獲董事會正式授權批准,並符合香港聯交所主板上市規則。
歌禮製藥有限公司於2024年2月22日向香港聯合交易所有限公司提交了翌日披露報表,披露了自2023年12月19日至2024年2月22日期間,公司未註銷的股份購回情況。根據報表,公司在此期間共購回了69,771,000股普通股,佔已發行股份的6.4179%。最後一次購回發生在2024年2月22日,當日購回480,000股,每股價格介乎HKD 1.87至HKD 1.9,總共支付了HKD 908,150。購回後,公司於2024年2月22日的結存為1,044,821,000股。公司確認,所有購回行動均獲董事會正式授權批准,並符合香港聯交所主板上市規則。
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 22 FEBRUARY 2024, DISCLOSING THE REPURCHASE OF UNREGISTERED SHARES FROM 19 DECEMBER 2023 TO 22 FEBRUARY 2024. According to the report, the company repurchased a total of 69,771,000 shares of ordinary shares during this period, representing 6.4179 percent of the issued shares. The last repurchase took place on 22 February 2024, repurchasing 480,000 shares at a price of HKD 1.87 to HKD 1.9 per share, with a total payment of HKD 908,150. After the repurchase, the company had a deposit of 1,044,821,000 shares on February 22, 2024. The Company confirms that all repurchases have been formally authorised by the Board of Directors and comply with the listing rules of the HKEX Main Board.
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 22 FEBRUARY 2024, DISCLOSING THE REPURCHASE OF UNREGISTERED SHARES FROM 19 DECEMBER 2023 TO 22 FEBRUARY 2024. According to the report, the company repurchased a total of 69,771,000 shares of ordinary shares during this period, representing 6.4179 percent of the issued shares. The last repurchase took place on 22 February 2024, repurchasing 480,000 shares at a price of HKD 1.87 to HKD 1.9 per share, with a total payment of HKD 908,150. After the repurchase, the company had a deposit of 1,044,821,000 shares on February 22, 2024. The Company confirms that all repurchases have been formally authorised by the Board of Directors and comply with the listing rules of the HKEX Main Board.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more